🇺🇸 SRPT — Sarepta Therapeutics, Inc.

Salud Mantener
← Volver

Precio actual

17,82 USD

Máx. histórico

178,74

2145 días

Split 1:6 del 12/07/2012

Caída desde máximo

-90,03%

Rango 52 semanas

14,68 – 24,68

Variación hoy

+1,42%

Cierre anterior

17,57

Rango de hoy

17,52 – 18,77

Volumen hoy

2.596.193

Peor caída histórica

-98,17%

09/02/2000 → 18/12/2008

Recuperado en 3568 días

Volatilidad anualizada ⓘ

95,43%

Información
Nombre completo
Sarepta Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
835
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
21,64 USD (puede no estar actualizado)
Primera cotización
04/06/1997
Precio actualizado
hace 11 horas
Sobre la empresa

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Splits Registrados en el histórico de precios
Fecha Ratio
12/07/2012 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
05/04/2018 74,52 74,82 70,57 72,86 -1,49% 5,70% 1.238.200
04/04/2018 71,00 74,35 70,50 73,96 +1,92% 5,42% 802.000
03/04/2018 72,75 73,64 71,24 72,57 +1,10% 3,30% 1.244.700
02/04/2018 73,02 73,83 70,88 71,78 -3,12% 4,04% 1.023.700
29/03/2018 72,42 75,27 71,25 74,09 +3,29% 5,55% 1.112.100
28/03/2018 76,44 76,99 70,83 71,73 -6,08% 8,06% 1.906.500
27/03/2018 79,10 79,39 75,82 76,37 -3,48% 4,51% 1.170.500
26/03/2018 79,34 80,13 76,51 79,12 +1,70% 4,56% 851.400
23/03/2018 77,87 80,40 77,59 77,80 -0,38% 3,61% 923.600
22/03/2018 79,12 80,52 78,05 78,10 -2,27% 3,12% 718.500
21/03/2018 78,58 80,64 77,61 79,91 -0,76% 3,86% 1.114.700
20/03/2018 79,37 81,70 79,00 80,52 +2,21% 3,40% 867.200
19/03/2018 80,63 81,79 77,11 78,78 -2,64% 5,80% 1.208.200
16/03/2018 81,10 82,59 80,60 80,92 -0,37% 2,45% 1.846.700
15/03/2018 83,23 84,37 80,55 81,22 -1,28% 4,59% 1.393.200
14/03/2018 81,78 82,77 81,00 82,27 +1,69% 2,16% 1.160.800
13/03/2018 76,36 80,90 75,79 80,90 +2,28% 6,69% 2.194.700
12/03/2018 76,36 80,23 75,79 79,10 +6,37% 5,81% 2.786.100
09/03/2018 75,00 75,36 73,01 74,36 -0,29% 3,13% 1.268.900
08/03/2018 74,50 75,69 72,75 74,58 +0,34% 3,95% 1.167.100
07/03/2018 70,00 74,86 69,50 74,33 +4,10% 7,66% 1.865.900
06/03/2018 71,02 72,69 69,57 71,40 -0,07% 4,39% 1.336.500
05/03/2018 67,89 71,84 66,74 71,45 +5,14% 7,51% 2.258.200
02/03/2018 60,60 68,68 59,51 67,96 +9,42% 15,13% 3.261.200
01/03/2018 63,30 63,58 60,28 62,11 -1,05% 5,21% 1.322.100
28/02/2018 64,78 65,50 62,66 62,77 -2,73% 4,38% 890.400
27/02/2018 64,90 65,37 63,85 64,53 -0,69% 2,34% 763.200
26/02/2018 64,04 65,37 63,54 64,98 +1,67% 2,86% 767.500
23/02/2018 63,87 64,00 61,88 63,91 +1,43% 3,32% 975.800
22/02/2018 63,91 65,10 62,95 63,01 -0,33% 3,36% 1.366.000